Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.

Publication ,  Journal Article
Musselwhite, LW; Redding, TS; Sims, KJ; O'Leary, MC; Hauser, ER; Hyslop, T; Gellad, ZF; Sullivan, BA; Lieberman, D; Provenzale, D
Published in: BMC Cancer
November 12, 2019

BACKGROUND: Adapting screening strategy to colorectal cancer (CRC) risk may improve efficiency for all stakeholders however limited tools for such risk stratification exist. Colorectal cancers usually evolve from advanced neoplasms that are present for years. We applied the National Cancer Institute (NCI) CRC Risk Assessment Tool, which calculates future risk of CRC, to determine whether it could be used to predict current advanced neoplasia (AN) in a veteran cohort undergoing a baseline screening colonoscopy. METHODS: This was a prospective assessment of the relationship between future CRC risk predicted by the NCI tool, and the presence of AN at screening colonoscopy. Family, medical, dietary and physical activity histories were collected at the time of screening colonoscopy and used to calculate absolute CRC risk at 5, 10 and 20 years. Discriminatory accuracy was assessed. RESULTS: Of 3121 veterans undergoing screening colonoscopy, 94% had complete data available to calculate risk (N = 2934, median age 63 years, 100% men, and 15% minorities). Prevalence of AN at baseline screening colonoscopy was 11 % (N = 313). For tertiles of estimated absolute CRC risk at 5 years, AN prevalences were 6.54% (95% CI, 4.99, 8.09), 11.26% (95% CI, 9.28-13.24), and 14.21% (95% CI, 12.02-16.40). For tertiles of estimated risk at 10 years, the prevalences were 6.34% (95% CI, 4.81-7.87), 11.25% (95% CI, 9.27-13.23), and 14.42% (95% CI, 12.22-16.62). For tertiles of estimated absolute CRC risk at 20 years, current AN prevalences were 7.54% (95% CI, 5.75-9.33), 10.53% (95% CI, 8.45-12.61), and 12.44% (95% CI, 10.2-14.68). The area under the curve for predicting current AN was 0.60 (95% CI; 0.57-0.63, p < 0.0001) at 5 years, 0.60 (95% CI, 0.57-0.63, p < 0.0001) at 10 years and 0.58 (95% CI, 0.54-0.61, p < 0.0001) at 20 years. CONCLUSION: The NCI tool had modest discriminatory function for estimating the presence of current advanced neoplasia in veterans undergoing a first screening colonoscopy. These findings are comparable to other clinically utilized cancer risk prediction models and may be used to inform the benefit-risk assessment of screening, particularly for patients with competing comorbidities and lower risk, for whom a non-invasive screening approach is preferred.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMC Cancer

DOI

EISSN

1471-2407

Publication Date

November 12, 2019

Volume

19

Issue

1

Start / End Page

1097

Location

England

Related Subject Headings

  • Veterans
  • United States
  • Risk Factors
  • Risk Assessment
  • ROC Curve
  • Public Health Surveillance
  • Oncology & Carcinogenesis
  • National Cancer Institute (U.S.)
  • Middle Aged
  • Mass Screening
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Musselwhite, L. W., Redding, T. S., Sims, K. J., O’Leary, M. C., Hauser, E. R., Hyslop, T., … Provenzale, D. (2019). Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool. BMC Cancer, 19(1), 1097. https://doi.org/10.1186/s12885-019-6204-1
Musselwhite, Laura W., Thomas S. Redding, Kellie J. Sims, Meghan C. O’Leary, Elizabeth R. Hauser, Terry Hyslop, Ziad F. Gellad, Brian A. Sullivan, David Lieberman, and Dawn Provenzale. “Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.BMC Cancer 19, no. 1 (November 12, 2019): 1097. https://doi.org/10.1186/s12885-019-6204-1.
Musselwhite LW, Redding TS, Sims KJ, O’Leary MC, Hauser ER, Hyslop T, et al. Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool. BMC Cancer. 2019 Nov 12;19(1):1097.
Musselwhite, Laura W., et al. “Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.BMC Cancer, vol. 19, no. 1, Nov. 2019, p. 1097. Pubmed, doi:10.1186/s12885-019-6204-1.
Musselwhite LW, Redding TS, Sims KJ, O’Leary MC, Hauser ER, Hyslop T, Gellad ZF, Sullivan BA, Lieberman D, Provenzale D. Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool. BMC Cancer. 2019 Nov 12;19(1):1097.
Journal cover image

Published In

BMC Cancer

DOI

EISSN

1471-2407

Publication Date

November 12, 2019

Volume

19

Issue

1

Start / End Page

1097

Location

England

Related Subject Headings

  • Veterans
  • United States
  • Risk Factors
  • Risk Assessment
  • ROC Curve
  • Public Health Surveillance
  • Oncology & Carcinogenesis
  • National Cancer Institute (U.S.)
  • Middle Aged
  • Mass Screening